Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Addressing Emerging Infectious Diseases and Related Public Health Concerns in India, Funding Opportunity Announcement (FOA) GH10-002, Initial Review, 28810 [2010-12356]

Download as PDF 28810 Federal Register / Vol. 75, No. 99 / Monday, May 24, 2010 / Notices ADSSP state grantees, as well as basic demographic information about service recipients. This revised version includes some revisions to the approved 2007 version. The revised version would be in effect for the FY2011 reporting year and thereafter, while the current reporting tool, OMB Approval Number 0985–0022, would be extended to the end of the FY2010 reporting cycle. The proposed FY2011 ADSSP–DCRT can be found on AoA’s Web site at: https://www.aoa.gov/AoARoot/ AoA_Programs/HCLTC/Alz_Grants/ docs/ADSSP.pdf. AoA estimates the burden of this collection of information as follows: 1410 hours. limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: May 14, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Dated: May 18, 2010. Ann Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. Centers for Disease Control and Prevention Dated: May 18, 2010. Kathy Greenlee, Assistant Secretary for Aging. BILLING CODE 4140–01–P [FR Doc. 2010–12446 Filed 5–21–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–12357 Filed 5–21–10; 8:45 am] BILLING CODE 4154–01–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting WReier-Aviles on DSKGBLS3C1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; LPR. Date: May 28, 2010. Time: 9 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Room 3AN12B, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Helen R. Sunshine, PhD, Chief, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN–12F, Bethesda, MD 20892, (301) 594–2881, sunshinh@nigms.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing VerDate Mar<15>2010 14:51 May 21, 2010 Jkt 220001 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Conducting Public Health Research in Kenya (Panel C), Funding Opportunity Announcement (FOA) GH10–003, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 12 p.m.–3 p.m., June 24, 2010 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Conducting Public Health Research in Kenya (Panel C),’’ FOA GH10– 003. Contact Person for More Information: Christine Morrison, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00034 Fmt 4703 Sfmt 9990 [FR Doc. 2010–12355 Filed 5–21–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Addressing Emerging Infectious Diseases and Related Public Health Concerns in India, Funding Opportunity Announcement (FOA) GH10–002, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11 a.m.–2 p.m., July 1, 2010 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Addressing Emerging Infectious Diseases and Related Public Health Concerns in India,’’ FOA GH10–002. Contact Person for More Information: Hylan D. Shoob, PhD, M.S.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–4796. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 14, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–12356 Filed 5–21–10; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\24MYN1.SGM 24MYN1

Agencies

[Federal Register Volume 75, Number 99 (Monday, May 24, 2010)]
[Notices]
[Page 28810]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12356]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Addressing Emerging Infectious Diseases and 
Related Public Health Concerns in India, Funding Opportunity 
Announcement (FOA) GH10-002, Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 11 a.m.-2 p.m., July 1, 2010 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Addressing Emerging Infectious Diseases and Related 
Public Health Concerns in India,'' FOA GH10-002.
    Contact Person for More Information: Hylan D. Shoob, PhD, 
M.S.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., 
Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639-4796.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 14, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-12356 Filed 5-21-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.